These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Clinical translation of a PSMA inhibitor for Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503 [TBL] [Abstract][Full Text] [Related]
45. A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer. Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H Mol Imaging Biol; 2017 Dec; 19(6):915-922. PubMed ID: 28924629 [TBL] [Abstract][Full Text] [Related]
46. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy. Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024 [TBL] [Abstract][Full Text] [Related]
47. Automated synthesis of [ Wurzer A; Di Carlo D; Herz M; Richter A; Robu S; Schirrmacher R; Mascarin A; Weber W; Eiber M; Schwaiger M; Wester HJ EJNMMI Radiopharm Chem; 2021 Jan; 6(1):4. PubMed ID: 33484364 [TBL] [Abstract][Full Text] [Related]
48. Gallium-68 DOTATATE Production with Automated PET Radiopharmaceutical Synthesis System: A Three Year Experience. Aslani A; Snowdon GM; Bailey DL; Schembri GP; Bailey EA; Roach PJ Asia Ocean J Nucl Med Biol; 2014; 2(2):75-86. PubMed ID: 27408863 [TBL] [Abstract][Full Text] [Related]
49. Cyclotron-based production of Rodnick ME; Sollert C; Stark D; Clark M; Katsifis A; Hockley BG; Parr DC; Frigell J; Henderson BD; Abghari-Gerst M; Piert MR; Fulham MJ; Eberl S; Gagnon K; Scott PJH EJNMMI Radiopharm Chem; 2020 Nov; 5(1):25. PubMed ID: 33180205 [TBL] [Abstract][Full Text] [Related]
50. Automated GMP-Compliant Production of [ Wagner M; Doverfjord JG; Tillner J; Antoni G; Haack T; Bossart M; Laitinen I; Johansson L; Pierrou S; Eriksson O; Velikyan I Pharmaceuticals (Basel); 2020 Jul; 13(8):. PubMed ID: 32752075 [No Abstract] [Full Text] [Related]
51. Installation and Optimization of Tayal S; Ali A; Kumar V; Jha AK; Gandhi A Indian J Nucl Med; 2021; 36(3):282-287. PubMed ID: 34658552 [TBL] [Abstract][Full Text] [Related]
52. An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution. Iudicello A; Genovese F; Di Iorio V; Cicoria G; Boschi S EJNMMI Radiopharm Chem; 2021 Mar; 6(1):14. PubMed ID: 33761040 [TBL] [Abstract][Full Text] [Related]
53. Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals. de Blois E; de Zanger RMS; Chan HS; Konijnenberg M; Breeman WAP EJNMMI Radiopharm Chem; 2019 Jan; 4(1):3. PubMed ID: 31659493 [TBL] [Abstract][Full Text] [Related]
54. Fully-automated production of [ Spreckelmeyer S; Balzer M; Poetzsch S; Brenner W EJNMMI Radiopharm Chem; 2020 Dec; 5(1):31. PubMed ID: 33331982 [TBL] [Abstract][Full Text] [Related]
58. GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use. Vis R; Lavalaye J; van de Garde EM EJNMMI Res; 2015; 5():27. PubMed ID: 25932354 [TBL] [Abstract][Full Text] [Related]
59. Fully-automated production of [ Spreckelmeyer S; Schulze O; Brenner W EJNMMI Radiopharm Chem; 2020 Feb; 5(1):8. PubMed ID: 32107654 [TBL] [Abstract][Full Text] [Related]
60. Design, construction and testing of a low-cost automated (68)Gallium-labeling synthesis unit for clinical use. Heidari P; Szretter A; Rushford LE; Stevens M; Collier L; Sore J; Hooker J; Mahmood U Am J Nucl Med Mol Imaging; 2016; 6(3):176-84. PubMed ID: 27508104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]